Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine

被引:55
作者
Wad, N [1 ]
Krämer, G [1 ]
机构
[1] Swiss Epilepsy Ctr, CH-8008 Zurich, Switzerland
来源
JOURNAL OF CHROMATOGRAPHY B | 1998年 / 705卷 / 01期
关键词
gabapentin; vigabatrin;
D O I
10.1016/S0378-4347(97)00521-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Serum concentrations of the antiepileptic drug gabapentin (GBP) are usually determined by high-performance liquid chromatography (HPLC) using UV photometric detection after pre-column derivatization with 2,4,6-trinitrobenzenesulphonic acid. Vigabatrin levels in serum are determined by HPLC using fluorescence detection. Like vigabatrin (VGB), gabapentin has also a primary amine group that easily reacts with o-phthaldialdehyde reagent and produces a fluorescing substance. By the use of fluorometric detection, GBP can be determined more simply, sensitively and simultaneously with VGB. The day-to-day coefficient of variation for the determination of GBP in a pooled serum was 4.0% (n=17; serum concentration, 13.8 mu mol/l) and for VGB was 3.1% (n=21; serum concentration, 26.4 mu mol/l). The lower limit of detection is 0.5 mu mol/l for both drugs and the method is linear up to 500 mu mol/l for GBP and 1300 mu mol/l for VGB. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 7 条
[1]   GABAPENTIN - PHARMACOKINETICS, EFFICACY, AND SAFETY [J].
BEYDOUN, A ;
UTHMAN, BM ;
SACKELLARES, JC .
CLINICAL NEUROPHARMACOLOGY, 1995, 18 (06) :469-481
[2]   FLUORESCENCE PROPERTIES OF ORTHO-PHTHALDIALDEHYDE DERIVATIVES OF AMINO-ACIDS [J].
CHEN, RF ;
SCOTT, C ;
TREPMAN, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 576 (02) :440-455
[3]   DETERMINATION OF GABAPENTIN IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND PRE-COLUMN LABELING FOR ULTRAVIOLET DETECTION [J].
HENGY, H ;
KOLLE, EU .
JOURNAL OF CHROMATOGRAPHY, 1985, 341 (02) :473-478
[4]   Simultaneous HPLC determination of vigabatrin and gabapentin in serum with automated pre-injection derivatization [J].
Juergens, UH ;
May, TW ;
Rambeck, B .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1996, 19 (09) :1459-1471
[5]   VIGABATRIN (SABRIL) [J].
KURLAND, AH ;
BROWNE, TR .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (06) :560-568
[6]  
LENSMEYER GL, 1995, THER DRUG MONIT, V17, P251
[7]   DETERMINATION OF VIGABATRIN IN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
TSANACLIS, LM ;
WICKS, J ;
WILLIAMS, J ;
RICHENS, A .
THERAPEUTIC DRUG MONITORING, 1991, 13 (03) :251-253